Swiss pharmaceutical group Roche hopes to obtain fast-track US approval for a rapid diagnostic test for Ebola, its director general said in an interview published Sunday, amid the worst-ever outbreak of the killer disease.
The diagnostic test is ready for use in scientific research but the company now wants to register it for clinical use.
{iframe}http://news.yahoo.com/roche-seeks-fast-track-us-okay-ebola-diagnostic-153514549.html{/iframe}